(Q73365330)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11145482%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Cholinesterase inhibitors: expanding applications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11145482%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

J L Cummings

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11145482%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 December 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11145482%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11145482%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

356

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11145482%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

2024-2025

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11145482%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

9247

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11145482%20AND%20SRC:MED&resulttype=core&format=json

Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903393-6

7 January 2021

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903393-6

7 January 2021

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903393-6

7 January 2021

The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903393-6

7 January 2021

Cholinesterase inhibitors: A new class of psychotropic compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903393-6

7 January 2021

Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903393-6

7 January 2021

Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903393-6

7 January 2021

A new rating scale for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903393-6

7 January 2021

Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903393-6

7 January 2021

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903393-6

7 January 2021

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903393-6

7 January 2021

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903393-6

7 January 2021

Neuroleptic sensitivity in patients with senile dementia of Lewy body type

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903393-6

7 January 2021

10.1016/S0140-6736(00)03393-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11145482%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference